Osteonecrosis in HIV-infected patients treated with HAART: a case control study of predictors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-2652
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Osteonecrosis in HIV-infected patients treated with HAART: a case control study of predictors ; volume:11 ; number:1 ; day:10 ; month:11 ; year:2008 ; pages:1 ; date:12.2008
Journal of the International AIDS Society / International AIDS Society ; 11, Heft 1 (10.11.2008), 1, 12.2008
- Urheber
-
Mazzotta, E.
- Beteiligte Personen und Organisationen
-
Agostinone, A.
Sozio, F.
Pieri, A.
Polilli, E.
Zicolella, R.
Di Masi, F.
Alterio, L.
Parruti, G.
Di Matteo, L.
SpringerLink (Online service)
- DOI
-
10.1186/1758-2652-11-S1-P152
- URN
-
urn:nbn:de:1111-2016052055695
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mazzotta, E.
- Agostinone, A.
- Sozio, F.
- Pieri, A.
- Polilli, E.
- Zicolella, R.
- Di Masi, F.
- Alterio, L.
- Parruti, G.
- Di Matteo, L.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Use of once-daily raltegravir-based HAART in HIV-infected injection drug users
Anaemia in HIV-infected children: severity, types and effect on response to HAART
Anal and cervical cytologic abnormalities among HIV-infected women in the era of HAART
Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals
Assessing the effect of HAART on change in quality of life among HIV-infected women
Pre-HAART CD4+ T-lymphocytes as biomarkers of post-HAART immune recovery in HIV-infected children with or without TB co-infection
Predictors of HBeAg status and hepatitis B viraemia in HIV-infected patients with chronic hepatitis B in the HAART era in Brazil
Predictive effects of body mass index on immune reconstitution among HIV-infected HAART users in China
Hematological and clinical profiles of HIV-infected adults initiating Highly Active AntiRetroviral Therapy (Haart) in Uganda
Prevalence and risk factors for chronic obstructive lung disease in HIV-infected patients in the HAART era
Predictors of severe hyperbiliruniaemia in HIV-infected patients treated with atazanavir (ATV)
Highly active antiretroviral treatment (HAART) interruption leads to an increase in mitochondrial DNA content in HIV-infected children
Use of once-daily raltegravir-based HAART in HIV-infected injection drug users
Anaemia in HIV-infected children: severity, types and effect on response to HAART
Anal and cervical cytologic abnormalities among HIV-infected women in the era of HAART
Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals
Assessing the effect of HAART on change in quality of life among HIV-infected women
Pre-HAART CD4+ T-lymphocytes as biomarkers of post-HAART immune recovery in HIV-infected children with or without TB co-infection
Predictors of HBeAg status and hepatitis B viraemia in HIV-infected patients with chronic hepatitis B in the HAART era in Brazil
Predictive effects of body mass index on immune reconstitution among HIV-infected HAART users in China
Hematological and clinical profiles of HIV-infected adults initiating Highly Active AntiRetroviral Therapy (Haart) in Uganda
Prevalence and risk factors for chronic obstructive lung disease in HIV-infected patients in the HAART era
Predictors of severe hyperbiliruniaemia in HIV-infected patients treated with atazanavir (ATV)
Highly active antiretroviral treatment (HAART) interruption leads to an increase in mitochondrial DNA content in HIV-infected children
Use of once-daily raltegravir-based HAART in HIV-infected injection drug users
Anaemia in HIV-infected children: severity, types and effect on response to HAART
Anal and cervical cytologic abnormalities among HIV-infected women in the era of HAART
Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals
Assessing the effect of HAART on change in quality of life among HIV-infected women
Pre-HAART CD4+ T-lymphocytes as biomarkers of post-HAART immune recovery in HIV-infected children with or without TB co-infection
Predictors of HBeAg status and hepatitis B viraemia in HIV-infected patients with chronic hepatitis B in the HAART era in Brazil
Predictive effects of body mass index on immune reconstitution among HIV-infected HAART users in China
Hematological and clinical profiles of HIV-infected adults initiating Highly Active AntiRetroviral Therapy (Haart) in Uganda
Prevalence and risk factors for chronic obstructive lung disease in HIV-infected patients in the HAART era
Predictors of severe hyperbiliruniaemia in HIV-infected patients treated with atazanavir (ATV)